Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Association of Blood Marker of Inflammation in Late Adolescence With Premature Mortality.

Kantor ED, Udumyan R, Giovannucci EL, Valdimarsdottir UA, Signorello LB, Montgomery S, Fall K.

JAMA Pediatr. 2019 Sep 3. doi: 10.1001/jamapediatrics.2019.2835. [Epub ahead of print] No abstract available.

PMID:
31479147
2.

Socioenvironmental adversity and risk of prostate cancer in non-Hispanic black and white men.

Kantor ED, Haneuse S, Valdimarsdóttir UA, Williams DR, Signorello LB, Rider JR.

Cancer Causes Control. 2019 Sep;30(9):997-1007. doi: 10.1007/s10552-019-01196-w. Epub 2019 Jul 1.

PMID:
31264140
3.

Phthalate Exposure From Prescription Medications and Breast Cancer Risk.

Kantor ED, Romano ME.

J Clin Oncol. 2019 Jul 20;37(21):1775-1777. doi: 10.1200/JCO.19.01003. Epub 2019 Jun 7. No abstract available.

PMID:
31173558
4.

Allergies and Asthma in Relation to Cancer Risk.

Kantor ED, Hsu M, Du M, Signorello LB.

Cancer Epidemiol Biomarkers Prev. 2019 Aug;28(8):1395-1403. doi: 10.1158/1055-9965.EPI-18-1330. Epub 2019 Jun 5.

PMID:
31167755
5.

Trends in Sedentary Behavior Among the US Population, 2001-2016.

Yang L, Cao C, Kantor ED, Nguyen LH, Zheng X, Park Y, Giovannucci EL, Matthews CE, Colditz GA, Cao Y.

JAMA. 2019 Apr 23;321(16):1587-1597. doi: 10.1001/jama.2019.3636.

6.

Use of dietary supplements in relation to urinary phthalate metabolite concentrations: Results from the National Health and Nutrition Examination Survey.

Romano ME, O'Connell K, Du M, Rehm CD, Kantor ED.

Environ Res. 2019 May;172:437-443. doi: 10.1016/j.envres.2018.12.033. Epub 2018 Dec 17.

PMID:
30826666
7.

Glucosamine use and risk of colorectal cancer: results from the Cancer Prevention Study II Nutrition Cohort.

Kantor ED, Newton CC, Giovannucci EL, McCullough ML, Campbell PT, Jacobs EJ.

Cancer Causes Control. 2018 Mar;29(3):389-397. doi: 10.1007/s10552-018-1003-6. Epub 2018 Feb 6.

8.

Trends in Dietary Supplement Use Among US Adults From 1999-2012.

Kantor ED, Rehm CD, Du M, White E, Giovannucci EL.

JAMA. 2016 Oct 11;316(14):1464-1474. doi: 10.1001/jama.2016.14403.

9.

Use of glucosamine and chondroitin supplements in relation to risk of colorectal cancer: Results from the Nurses' Health Study and Health Professionals follow-up study.

Kantor ED, Zhang X, Wu K, Signorello LB, Chan AT, Fuchs CS, Giovannucci EL.

Int J Cancer. 2016 Nov 1;139(9):1949-57. doi: 10.1002/ijc.30250. Epub 2016 Jul 18.

10.

Factors Associated with Multiple Biomarkers of Systemic Inflammation.

Navarro SL, Kantor ED, Song X, Milne GL, Lampe JW, Kratz M, White E.

Cancer Epidemiol Biomarkers Prev. 2016 Mar;25(3):521-31. doi: 10.1158/1055-9965.EPI-15-0956. Epub 2016 Jan 11.

11.

Trends in Prescription Drug Use Among Adults in the United States From 1999-2012.

Kantor ED, Rehm CD, Haas JS, Chan AT, Giovannucci EL.

JAMA. 2015 Nov 3;314(17):1818-31. doi: 10.1001/jama.2015.13766.

12.

Adolescent Obesity and Inflammation in Relation to Colorectal Cancer Risk: Recent Findings and Future Implications.

Kantor ED, Giovannucci E.

Child Obes. 2015 Aug;11(4):335-7. doi: 10.1089/chi.2015.29001.ek. No abstract available.

13.

Effect of Traumatic Brain Injury, Erythropoietin, and Anakinra on Hepatic Metabolizing Enzymes and Transporters in an Experimental Rat Model.

Anderson GD, Peterson TC, Vonder Haar C, Farin FM, Bammler TK, MacDonald JW, Kantor ED, Hoane MR.

AAPS J. 2015 Sep;17(5):1255-67. doi: 10.1208/s12248-015-9792-y. Epub 2015 Jun 12.

14.

Statin use and risk of prostate cancer: Results from the Southern Community Cohort Study.

Kantor ED, Lipworth L, Fowke JH, Giovannucci EL, Mucci LA, Signorello LB.

Prostate. 2015 Sep;75(13):1384-93. doi: 10.1002/pros.23019. Epub 2015 May 27.

15.

Adolescent body mass index and erythrocyte sedimentation rate in relation to colorectal cancer risk.

Kantor ED, Udumyan R, Signorello LB, Giovannucci EL, Montgomery S, Fall K.

Gut. 2016 Aug;65(8):1289-95. doi: 10.1136/gutjnl-2014-309007. Epub 2015 May 18.

16.

Body mass index in young adulthood, obesity trajectory, and premature mortality.

Hirko KA, Kantor ED, Cohen SS, Blot WJ, Stampfer MJ, Signorello LB.

Am J Epidemiol. 2015 Sep 1;182(5):441-50. doi: 10.1093/aje/kwv084. Epub 2015 May 13.

17.

Gene-diet interactions and their impact on colorectal cancer risk.

Kantor ED, Giovannucci EL.

Curr Nutr Rep. 2015 Mar;4(1):13-21.

18.

Randomized trial of glucosamine and chondroitin supplementation on inflammation and oxidative stress biomarkers and plasma proteomics profiles in healthy humans.

Navarro SL, White E, Kantor ED, Zhang Y, Rho J, Song X, Milne GL, Lampe PD, Lampe JW.

PLoS One. 2015 Feb 26;10(2):e0117534. doi: 10.1371/journal.pone.0117534. eCollection 2015.

19.

A Combination Therapy of Nicotinamide and Progesterone Improves Functional Recovery following Traumatic Brain Injury.

Peterson TC, Hoane MR, McConomy KS, Farin FM, Bammler TK, MacDonald JW, Kantor ED, Anderson GD.

J Neurotrauma. 2015 Jun 1;32(11):765-79. doi: 10.1089/neu.2014.3530. Epub 2015 Feb 26.

20.

A prospective study of the effect of bowel movement frequency, constipation, and laxative use on colorectal cancer risk.

Citronberg J, Kantor ED, Potter JD, White E.

Am J Gastroenterol. 2014 Oct;109(10):1640-9. doi: 10.1038/ajg.2014.233. Epub 2014 Sep 16.

21.

Gene-environment interaction involving recently identified colorectal cancer susceptibility Loci.

Kantor ED, Hutter CM, Minnier J, Berndt SI, Brenner H, Caan BJ, Campbell PT, Carlson CS, Casey G, Chan AT, Chang-Claude J, Chanock SJ, Cotterchio M, Du M, Duggan D, Fuchs CS, Giovannucci EL, Gong J, Harrison TA, Hayes RB, Henderson BE, Hoffmeister M, Hopper JL, Jenkins MA, Jiao S, Kolonel LN, Le Marchand L, Lemire M, Ma J, Newcomb PA, Ochs-Balcom HM, Pflugeisen BM, Potter JD, Rudolph A, Schoen RE, Seminara D, Slattery ML, Stelling DL, Thomas F, Thornquist M, Ulrich CM, Warnick GS, Zanke BW, Peters U, Hsu L, White E.

Cancer Epidemiol Biomarkers Prev. 2014 Sep;23(9):1824-33. doi: 10.1158/1055-9965.EPI-14-0062. Epub 2014 Jul 3.

22.

Associations between glucosamine and chondroitin supplement use and biomarkers of systemic inflammation.

Kantor ED, Lampe JW, Navarro SL, Song X, Milne GL, White E.

J Altern Complement Med. 2014 Jun;20(6):479-85. doi: 10.1089/acm.2013.0323. Epub 2014 Apr 16.

23.

Intake of long-chain ω-3 fatty acids from diet and supplements in relation to mortality.

Bell GA, Kantor ED, Lampe JW, Kristal AR, Heckbert SR, White E.

Am J Epidemiol. 2014 Mar 15;179(6):710-20. doi: 10.1093/aje/kwt326. Epub 2014 Feb 3.

24.

Comparison of the effect of minocycline and simvastatin on functional recovery and gene expression in a rat traumatic brain injury model.

Vonder Haar C, Anderson GD, Elmore BE, Moore LH, Wright AM, Kantor ED, Farin FM, Bammler TK, MacDonald JW, Hoane MR.

J Neurotrauma. 2014 May 15;31(10):961-75. doi: 10.1089/neu.2013.3119. Epub 2014 Jan 20.

25.

Comparison of the effects of erythropoietin and anakinra on functional recovery and gene expression in a traumatic brain injury model.

Anderson GD, Peterson TC, Vonder Haar C, Kantor ED, Farin FM, Bammler TK, Macdonald JW, Hoane MR.

Front Pharmacol. 2013 Oct 17;4:129. doi: 10.3389/fphar.2013.00129. eCollection 2013.

26.

Eating frequency and risk of colorectal cancer.

Perrigue MM, Kantor ED, Hastert TA, Patterson R, Potter JD, Neuhouser ML, White E.

Cancer Causes Control. 2013 Dec;24(12):2107-15. doi: 10.1007/s10552-013-0288-8. Epub 2013 Sep 21.

27.

Long-chain omega-3 polyunsaturated fatty acid intake and risk of colorectal cancer.

Kantor ED, Lampe JW, Peters U, Vaughan TL, White E.

Nutr Cancer. 2014;66(4):716-27. doi: 10.1080/01635581.2013.804101. Epub 2013 Sep 20.

28.

Specialty supplement use and biologic measures of oxidative stress and DNA damage.

Kantor ED, Ulrich CM, Owen RW, Schmezer P, Neuhouser ML, Lampe JW, Peters U, Shen DD, Vaughan TL, White E.

Cancer Epidemiol Biomarkers Prev. 2013 Dec;22(12):2312-22. doi: 10.1158/1055-9965.EPI-13-0470. Epub 2013 Aug 5.

29.

Lifestyle factors and inflammation: associations by body mass index.

Kantor ED, Lampe JW, Kratz M, White E.

PLoS One. 2013 Jul 2;8(7):e67833. doi: 10.1371/journal.pone.0067833. Print 2013.

30.

Assessment of diagnosis of inflammatory breast cancer cases at two cancer centers in Egypt and Tunisia.

Schairer C, Soliman AS, Omar S, Khaled H, Eissa S, Ayed FB, Khalafallah S, Ayoub WB, Kantor ED, Merajver S, Swain SM, Gail M, Brown LM.

Cancer Med. 2013 Apr;2(2):178-84. doi: 10.1002/cam4.48. Epub 2013 Jan 24.

31.

The effect of nicotinamide on gene expression in a traumatic brain injury model.

Anderson GD, Peterson TC, Farin FM, Bammler TK, Beyer RP, Kantor ED, Hoane MR.

Front Neurosci. 2013 Feb 26;7:21. doi: 10.3389/fnins.2013.00021. eCollection 2013.

32.

Use of glucosamine and chondroitin supplements and risk of colorectal cancer.

Kantor ED, Lampe JW, Peters U, Shen DD, Vaughan TL, White E.

Cancer Causes Control. 2013 Jun;24(6):1137-46. doi: 10.1007/s10552-013-0192-2. Epub 2013 Mar 26.

33.

Genome-wide search for gene-gene interactions in colorectal cancer.

Jiao S, Hsu L, Berndt S, Bézieau S, Brenner H, Buchanan D, Caan BJ, Campbell PT, Carlson CS, Casey G, Chan AT, Chang-Claude J, Chanock S, Conti DV, Curtis KR, Duggan D, Gallinger S, Gruber SB, Harrison TA, Hayes RB, Henderson BE, Hoffmeister M, Hopper JL, Hudson TJ, Hutter CM, Jackson RD, Jenkins MA, Kantor ED, Kolonel LN, Küry S, Le Marchand L, Lemire M, Newcomb PA, Potter JD, Qu C, Rosse SA, Schoen RE, Schumacher FR, Seminara D, Slattery ML, Ulrich CM, Zanke BW, Peters U.

PLoS One. 2012;7(12):e52535. doi: 10.1371/journal.pone.0052535. Epub 2012 Dec 26.

34.

Association between use of specialty dietary supplements and C-reactive protein concentrations.

Kantor ED, Lampe JW, Vaughan TL, Peters U, Rehm CD, White E.

Am J Epidemiol. 2012 Dec 1;176(11):1002-13. doi: 10.1093/aje/kws186. Epub 2012 Nov 8.

35.

A comparison of the effects of nicotinamide and progesterone on functional recovery of cognitive behavior following cortical contusion injury in the rat.

Peterson TC, Anderson GD, Kantor ED, Hoane MR.

J Neurotrauma. 2012 Dec 10;29(18):2823-30. doi: 10.1089/neu.2012.2471. Epub 2012 Nov 27.

36.

Inflammatory breast cancer in north Africa: comparison of clinical and molecular epidemiologic characteristics of patients from Egypt, Tunisia, and Morocco.

Soliman AS, Kleer CG, Mrad K, Karkouri M, Omar S, Khaled HM, Benider AL, Ayed FB, Eissa SS, Eissa MS, McSpadden EJ, Lo AC, Toy K, Kantor ED, Xiao Q, Hampton C, Merajver SD.

Breast Dis. 2011-2012;33(4):159-69. doi: 10.3233/BD-2012-000337.

37.

Use of glucosamine and chondroitin in relation to mortality.

Bell GA, Kantor ED, Lampe JW, Shen DD, White E.

Eur J Epidemiol. 2012 Aug;27(8):593-603. doi: 10.1007/s10654-012-9714-6. Epub 2012 Jul 25.

38.

Use of statin medications and risk of esophageal adenocarcinoma in persons with Barrett's esophagus.

Kantor ED, Onstad L, Blount PL, Reid BJ, Vaughan TL.

Cancer Epidemiol Biomarkers Prev. 2012 Mar;21(3):456-61. doi: 10.1158/1055-9965.EPI-11-1014. Epub 2012 Jan 12.

39.

The effect of progesterone dose on gene expression after traumatic brain injury.

Anderson GD, Farin FM, Bammler TK, Beyer RP, Swan AA, Wilkerson HW, Kantor ED, Hoane MR.

J Neurotrauma. 2011 Sep;28(9):1827-43. doi: 10.1089/neu.2011.1911. Epub 2011 Sep 8.

40.

Ketorolac tromethamine: stereo-specific pharmacokinetics and single-dose use in postoperative infants aged 2-6 months.

Lynn AM, Bradford H, Kantor ED, Andrew M, Vicini P, Anderson GD.

Paediatr Anaesth. 2011 Mar;21(3):325-34. doi: 10.1111/j.1460-9592.2010.03484.x. Epub 2010 Dec 29.

41.

Postoperative ketorolac tromethamine use in infants aged 6-18 months: the effect on morphine usage, safety assessment, and stereo-specific pharmacokinetics.

Lynn AM, Bradford H, Kantor ED, Seng KY, Salinger DH, Chen J, Ellenbogen RG, Vicini P, Anderson GD.

Anesth Analg. 2007 May;104(5):1040-51, tables of contents.

PMID:
17456651
42.

Pharmacokinetics of valerenic acid after administration of valerian in healthy subjects.

Anderson GD, Elmer GW, Kantor ED, Templeton IE, Vitiello MV.

Phytother Res. 2005 Sep;19(9):801-3.

PMID:
16220575
43.

Lorazepam-valproate interaction: studies in normal subjects and isolated perfused rat liver.

Anderson GD, Gidal BE, Kantor ED, Wilensky AJ.

Epilepsia. 1994 Jan-Feb;35(1):221-5.

PMID:
8112251

Supplemental Content

Loading ...
Support Center